The emerging role of FK506-binding proteins as cancer biomarkers: A focus on FKBPL

Biochemical Society Transactions

Volumn 39, Issue 2, 2011, Pages 663-668

  McKeen, Hayley D ^a   Brennan, Donal J ^b   Hegarty, Shauna ^a   Lanigan, Fiona ^b   Jirstrom, Karin ^c   Byrne, Christopher ^a   Yakkundi, Anita ^a   McCarthy, Helen O ^a   Gallagher, William M ^b   Robson, Tracy ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Cancer biomarker; FK506 binding protein (FKBP); FK506 binding protein like (FKBPL); Glucocorticoid receptor (GR); Oestrogen; Steroid receptor

Indexed keywords

ANDROGEN RECEPTOR; CD44V ANTIGEN; CYTOPLASMIC DYNEIN; DNA TOPOISOMERASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; ESTROGEN RECEPTOR; FK 506 BINDING PROTEIN; FULVESTRANT; GELATINASE B; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 90; MICROTUBULE PROTEIN; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; PROTEIN P21; RAPAMYCIN; STEROID RECEPTOR; SYNDECAN 1; TAMOXIFEN; TUMOR MARKER;

ADULT; ANGIOGENESIS; AZOOSPERMIA; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER GRADING; CANCER HORMONE THERAPY; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CELL ADHESION; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 6P; COLORECTAL CARCINOMA; CONCENTRATION (PARAMETERS); DISEASE FREE SURVIVAL; DOWN REGULATION; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG TARGETING; EXTRACELLULAR MATRIX; GENE CONTROL; GENE LOCATION; GENE MUTATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; IONIZING RADIATION; LIGAND BINDING; LUNG CANCER; MAJOR CLINICAL STUDY; MALE INFERTILITY; MELANOMA CELL; NEOPLASM; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TRANSPORT; RADIATION DOSE; RADIOSENSITIVITY; REVIEW; SARCOMA; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR VOLUME;

ANIMALS; HUMANS; IMMUNOPHILINS; MODELS, BIOLOGICAL; NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TACROLIMUS BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953188016     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390663     Document Type: Review

References (43)

1. Veeraraghavan, S and Nall, B.T. (1994) Characterisation of folding intermediates using prolyl isomerase. Biochemistry 33, 687-692 (Pubitemid 24064106)
2. Ratajczak, T. and Carrello, A. (1996) Cyclophilin 40 (CyP-40), mapping of its hsp90 binding domain and evidence that FKBP52 competes with CyP-40 for hsp90 binding. J. Biol. Chem. 271, 2961-2965
3. Young, J.C., Obermann, W.M. and Hartl, F.U. (1998) Specific binding of tetratricopeptide repeat proteins to the C-terminal 12-kDa domain of hsp90. J. Biol. Chem. 273, 18007-18010
4. Schreiber, S.L. and Crabtree, G.R. (1992) The mechanism of action of cyclosporin A and FK506. Immunol. Today 13, 136-142
5. Pratt, W.B. and Toft, D.O. (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrinol. Rev. 18, 306-360
6. Robson, T.A., Lohrer, H, Bailie, J.R., Hirst, D.G., Joiner, M.C. and Arrand, J.E. (1997) Gene regulation by low-dose ionizing radiation in a normal human lung epithelial cell line. Biochem. Soc. Trans. 25, 335-342
7. Robson, T., Joiner, M.C., Wilson, G.D., McCullough, W., Price, M.E., Logan, I., Jones, H., McKeown, S.R. and Hirst, D.G. (1999) A novel human stress response-related gene with a potential role in induced radioresistance. Radiat. Res. 152, 451-61
8. Robson, T., Price, M.E., Moore, M.L., Joiner, M.C, McKelvey-Martin, V.J., McKeown, S.R. and Hirst, D.G. (2000) Increased repair and cell survival in cells treated with DIR1 antisense oligonucleotides: implications for induced radioresistance. Int. J. Radiat. Biol. 76, 617-623
9. WAF1/CIP1 stability by WISp39, a Hsp90 binding TPR protein. Mol. Cell 17, 237-249
10. CIP1/WAF1 stability conferring resistance to paclitaxel treatment. J. Biol. Chem. 285, 5274-5281
11. DeFranco, D.B. (2002) Functional implications of glucocorticoid receptor trafficking. Ernst Schering Res. Found. Workshop 40, 939-946
12. Silverstein, A.M, Galigniana, M.D., Kanelakis, K.C, Radanyi, C., Renoir, J.M. and Pratt, W.B. (1999) Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90 and cytoplasmic dynein. J. Biol. Chem. 274, 36980-36986
13. Czar, M.J., Lyons, R.H., Welsh, M.J., Renoir, J.M. and Pratt, W.B. (1995) Evidence that the FK506-binding immunophilin heat shock protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol. Endocrinol. 9, 1549-1560
14. Galigniana, M.D., Scruggs, J.L., Herrington, J., Welsh, M.J., Carter-Su, C., Housley, P.R. and Pratt, W.B. (1998) Heat shock protein 90-dependent galdanamycin-inhibited movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol. Endocrinol. 12, 1903-1913
15. Galigniana, M.D., Radanyi, C., Renoir, J.M, Housley, P.R. and Pratt, W.B. (2001) Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus. J. Biol. Chem. 276, 14884-14889
16. McKeen, H.D., McAlpine, K., Valentine, A., Quinn, D.J., McClelland, K., Byrne, C., O'Rourke, M., Young, S., Scott, C.J., McCarthy, H.O. et al. (2008) A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling. Endocrinology 149, 5724-5734
17. Mukaide, H., Adachi, Y., Taketani, S., Iwasaki, M., Koike-Kiriyama, N., Shigematsu, A., Shi, M., Yanai, S., Yoshioka, K., Kamiyama, Y. and Ikehara, S. (2008) FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma. Cancer Invest. 26, 385-390 (Pubitemid 351601395)
18. Velasco, A.M., Gillis, K.A., Li, Y., Brown, E.L., Sadler, T.M., Achilleos, M., Greenberger, L.M., Frost, P., Bai, W. and Zhang, Y. (2004) Identification and validation of novel androgen-regulated gene in prostate cancer. Endocrinology 145, 3913-3924 (Pubitemid 39037580)
19. Febbo, P.G., Lowenberg, M., Thorner, A.R., Brown, M., Loda, M. and Golub, T.R. (2005) Androgen mediated regulation and functional implications of FKBP51 expression in prostate cancer. J. Urol. 173, 1772-1777 (Pubitemid 40524830)
20. Ni, L., Yang, C., Gioeli, D., Frierson, H., Toft, D.O. and Paschal, B.M. (2010) FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells. Mol. Cell Biol. 30, 1243-1253
21. Lin, J., X, J., Tian, H., Gao, X., Chen, Q., Gu, Q., Xu, G., Song, J. and Zhao, F. (2007) Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis. Int. J. Cancer. 121, 2596-2605
22. Cheung-Flynn, J., Prapapanich, V., Cox, M.B., Riggs, D.L., Suarez-Quian, C. and Smith, D.F. (2005) Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol. Endocrinol. 19, 1654-1666
23. Yong, W., Yang, Z., Periyasamy, S., Chen, H., Yucel, S., Li, W., Lin, L.Y., Wolf, I.M., Cohn, M.J., Baskin, L.S. et al. (2007) Essential role for co-chaperone FKBP52 but not FKBP51 in androgen receptor-mediated signaling and physiology. J. Biol. Chem. 282, 5026-5036
24. Tsujimura, A., Ota, M., Katsuyama, Y., Sada, M., Miura, H., Matsumiya, K., Gotoh, R., Nakatani, T., Okuyama, A. and Takahura, S. (2002) Susceptibility gene for non-obstructive azoospermia located near HLA-DR and -DQ loci in the HLA class II region. Hum. Genet. 110, 192-197
25. Sunnotel, O., Hiripi, L., Lagan, K., McDaid, J.R., De Leon, J.M., Miyagawa, Y., Crowe, H., Kaluskar, S., Ward, M., Scullion, C. et al. (2010) Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility a case control study. Reprod. Biol. Endocrinol. 8, 22-29
26. Kumar, P., Mark, P.J., Ward, B.K., Minchin, R.F. and Ratajczak, T. (2001) Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 284, 219-225
27. Ward, B.K., Mark, P.J., Ingram, D.M., Minchin, R.F. and Ratajczak, T. (1999) Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res. Treat. 58, 267-280
28. Desmetz, C., Bascoul-Mollevi, C., Rochaix, P., Lamy, P., Kramar, A., Rouanet, P., Maudelonde, T., Mange, A. and Solassol, J. (2009) Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. Clin. Cancer Res. 15, 4733-4741
29. Ostrow, K.L., Park, H.L., Hoque, M.O., Kim, M.S., Liu, J., Argani, P., Westra, W., Criekinge, W.V. and Sidransky, D. (2009) Pharmacologic unmasking of epigenetically silenced genes in breast cancer. Clin. Cancer Res. 15, 1184-1191
30. McKeen, H.D., Byrne, C., Jithesh, P.V., Donley, C., Valentine, A., Yakkundi, A., O'Rourke, M., Swanton, C., McCarthy, H.O., Hirst, D.G. and Robson, T. (2010) FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy. Cancer Res. 70, 1090-1100
31. Eckert, R.L., Mullick, A., Rorke, E.A. and Katzenellenbogen, B.S. (1984) Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. Endocrinology 114, 629-637 (Pubitemid 14183269)
32. Abukhdeir, A.M., Vitolo, M.I., Argani, P., De Marzo, A.M., Karakas, B., Konishi, H., Gustin, J.P., Lauring, J., Garay, J.P., Pendleton, C. et al. (2008) Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proc. Natl. Acad. Sci. U.S.A. 105, 288-293
33. Halatsch, M.E., Low, S., Hielscher, T., Schmidt, U., Unterberg, A. and Vougioukas, V.I. (2008) Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinib. Anticancer Res. 28, 3725-3728
34. Jiang, W., Cazacu, S., Xiang, C., Zenklusen, J.C., Fine, H.A., Berens, M., Armstrong, B., Brodie, C. and Mikkelsen, T. (2008) FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-κB signaling pathway. Neoplasia 10, 235-243
35. Pei, H., Li, L., Fridley, B.L., Jenkins, G.D., Kalari, K.R., Lingle, W., Petersen, G., Lou, Z. and Wang, L. (2009) FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16, 259-266
36. Romano, S., D'Angelillo, A., Pacelli, R., Staibano, S., De Luna, E., Bisogni, R., Eskelinen, E.-L., Mascolo, M., Cali, G., Arra, C. and Romano, M.F. (2010) Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells. Cell Death Differ. 17, 145-157
37. Olesen, S.H., Christensen, L.L., Sorensen, F.B., Cabezon, T., Laurberg, S., Orntoft, T.F. and Birkenkamp-Demtroder, K. (2005) Human FK506 binding protein 65 is associated with colorectal cancer. Mol. Cell. Proteomics 4, 534-544
38. Fong, S., Mounkes, L., Liu, Y., Maibaum, M., Alonzo, E., Desprez, P.-Y., Thor, A.D., Kashani-Sabet, M. and Debs, R.J. (2003) Functional identification of distinct sets of antitumour activities mediated by the FKBP gene family. Proc. Natl. Acad. Sci. U.S.A. 100, 14253-14258
39. Khatua, S., Peterson, K.M., Brown, K.M., Lawlor, C., Santi, M.R., LaFleur, B., Dressman, D., Stephan, D.A. and MacDonald, T.J. (2003) Overexpression of the EGFR/FKBP12/HIF-2α pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res. 63, 1685-1870
40. Valentine, A., O'Rourke, M., Yakkundi, A., Worthington, J., Hookham, M., Bicknell, R., McCarthy, H., McClelland, K., McCallum, L., Dyer, H. et al. (2011) FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism. Clin. Cancer Res. 17, 1044-1056
41. Li, Y.Y., Liu, L.Q., Yang, J., Liu, W., Chen, X.J., Li, X.Q., Du, W. and Huang, S.A (2007) Effect of WISp39 on proliferation, cell cycle and apoptosis of U937 cells. Zhongguo Shiyan Xueyexue Zazhi 15, 733-737
42. Han, W., Han, M.R., Kang, J.J., Bae, J.Y., Lee, J.H., Bae, Y.J., Lee, J.E., Shin, H.J., Hwang, K.T., Hwang, S.E. et al. (2006) Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. BMC Cancer 6, 92-104
43. Borgquist, S., Jögi, A., Pontén, F., Rydén, L., Brennan, D.J. and Jirström, K. (2008) Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer. Breast Cancer Res. 10, 79-89